SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-24-017051
Filing Date
2024-05-15
Accepted
2024-05-15 16:11:00
Documents
94
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q aytu20240331_10q.htm   iXBRL 10-Q 1349554
2 EXHIBIT 31.1 ex_630337.htm EX-31.1 13424
3 EXHIBIT 31.2 ex_630338.htm EX-31.2 13702
4 EXHIBIT 32.1 ex_630339.htm EX-32.1 8397
10 aytu20231231_10qimg001.jpg GRAPHIC 2569
  Complete submission text file 0001437749-24-017051.txt   8095753

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA aytu-20240331.xsd EX-101.SCH 77709
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aytu-20240331_cal.xml EX-101.CAL 61267
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aytu-20240331_def.xml EX-101.DEF 544909
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aytu-20240331_lab.xml EX-101.LAB 431249
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aytu-20240331_pre.xml EX-101.PRE 591370
98 EXTRACTED XBRL INSTANCE DOCUMENT aytu20240331_10q_htm.xml XML 1350381
Mailing Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237
Business Address 7900 E. UNION AVENUE SUITE 920 DENVER CO 80237 (720) 437-6580
AYTU BIOPHARMA, INC (Filer) CIK: 0001385818 (see all company filings)

IRS No.: 470883144 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-38247 | Film No.: 24950739
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)